ADJUVANCE TECHNOLOGIES INC
Lincoln, United States · Founded 2017 · $41.5M raised
- Headquarters
- Lincoln, Nebraska
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Website
- adjuvancetechnologies.org
- Total Funding
- $41.5M
- Last Round
- $20.0M Series AJan 2020
- Rounds
- 3
About
Adjuvance Technologies is a Lincoln, Nebraska biopharmaceutical company developing next-generation semi-synthetic saponin adjuvants to improve vaccine efficacy and duration. The company licenses its proprietary adjuvant platform to vaccine developers globally and has collaborated with Memorial Sloan-Kettering Cancer Center.
Summary
ADJUVANCE TECHNOLOGIES INC is a Biotech company based in Lincoln, United States, founded in 2017. It has raised $41.5M in total across 3 rounds, most recently a $20.0M Series A round in Jan 2020. Investors include 5Y Capital, Morningside Venture Investments and National Institutes of Health.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2020
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...